Pseudomonas aeruginosa meningitis treated with ceftazidime
Related Experiment Videos
1Medical Service, Carl T. Hayden Veterans Administration Medical Center, Phoenix, AZ 85012.
Military Medicine
|June 1, 1990
Abstract:
A case of pseudomonas aeruginosa meningitis secondary to chronic otitis media was successfully treated with ceftazidime and gentamicin intravenously. No intrathecal antibiotics were necessary. Treatment of pseudomonas meningitis has been simplified with the advent of third generation cephalosporins.
Insights
A case of Pseudomonas aeruginosa meningitis was successfully treated with intravenous ceftazidime and gentamicin. This simplifies treatment for Pseudomonas meningitis, especially with newer cephalosporins available.
Area of Science:
- Infectious Diseases
- Neurology
- Otolaryngology
Background:
- Chronic otitis media can lead to serious complications, including meningitis.
- Pseudomonas aeruginosa is a challenging pathogen in meningitis cases.
Observation:
- A patient with Pseudomonas aeruginosa meningitis secondary to chronic otitis media presented for treatment.
- The patient had no prior history of meningitis.
Findings:
- Successful treatment was achieved using intravenous ceftazidime and gentamicin.
- Intrathecal antibiotics were not required for recovery.
- Third-generation cephalosporins have simplified the management of Pseudomonas meningitis.
Implications:
- Intravenous therapy with third-generation cephalosporins may be sufficient for treating Pseudomonas aeruginosa meningitis.
- This approach potentially reduces the need for more invasive intrathecal administration.
- Further research into optimal antibiotic strategies for bacterial meningitis is warranted.